• Synaptic effects of interleukin-6 on human iPSC-derived dopaminergic neurons
  Published on 2026-01-13
  8 months ago
• Remission is insufficient: predictors and mechanistic models of recurrence in late-life depression
  Published on 2026-01-12
  8 months ago
• Modulation of hierarchical motor sequence learning by alpha-synuclein and the adenosine A2A receptor
  Published on 2026-01-12
  8 months ago
• From rest to focus: pharmacological modulation of the relationship between resting state dorsal attention network dynamics and task-based brain activation
  Published on 2026-01-12
  8 months ago
• Network-based analysis of differential white matter connectivity in major depressive disorder with and without comorbid anxiety
  Published on 2026-01-11
  8 months ago
• In memoriam – Robert M. Bilder, Ph.D.
  Published on 2026-01-09
  8 months ago
• Repeated restraint stress-induced increase in post-surgical somatosensory hypersensitivity and affective responding is mediated by β-adrenergic receptor activation and spinal NLRP3-IL1β signalling in male rats
  Published on 2026-01-08
  8 months ago

« Previous 1 … 34 35 36 37 38 … 143 Next »

• Retraction: The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis
  Published on 2025-05-16
  1 year ago
• Circadian rhythmicity in prepulse inhibition of the acoustic startle response: A study of chronotype and time-of-day effects in young healthy adults
  Published on 2025-05-15
  1 year ago
• CYP1A2 genotype-dependent effects of smoking on mirtazapine serum concentrations
  Published on 2025-05-12
  1 year ago
• Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review
  Published on 2025-05-12
  1 year ago
• The effects of menthol content on the abuse liability of smokeless tobacco in a randomized crossover trial
  Published on 2025-05-08
  1 year ago
• Brexpiprazole augmentation and mitochondrial gene expression changes in major depressive disorder
  Published on 2025-05-06
  1 year ago
• Are the LSD-analogs lisuride and ergotamine examples of non-hallucinogenic serotonin 5-HT2A receptor agonists?
  Published on 2025-05-05
  1 year ago

« Previous 1 … 34 35 36 37 38 … 154 Next »

• Differential effects of Xanomeline-trospium chloride on positive and negative symptoms in Schizophrenia: The role of dose
  Published on 2025-02-05
  2 years ago
• MiRNAs and extracellular vesicles in psychiatry: Potential biomarkers, therapeutic advances, and animal models
  Published on 2025-01-03
  2 years ago
• 3D imaging and geometric morphometrics of facial dysmorphology and asymmetry indicate gestational timings of dysmorphogenesis in schizophrenia and bipolar disorder
  Published on 2025-01-03
  2 years ago
• Disease-wide association study uncovers disease continuum network of unipolar depression
  Published on 2024-12-29
  2 years ago
• Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysis
  Published on 2024-12-26
  2 years ago
• Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach
  Published on 2024-12-25
  2 years ago
• Is creatine useful as adjuvant in cognitive-behavioural therapy for depression?
  Published on 2024-12-24
  2 years ago

« Previous 1 … 34 35 36 37 38 … 170 Next »